Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
16 February 2017
Header
Header image
News

News

EFPIA Welcomes the European Parliament’s green light to CETA
15 February 2017

The European Parliament has today given its consent to the EU-Canada Comprehensive Economic and Trade Agreement (CETA), which confirms the support of all EU institutions [...] Read more

News

EBE and EFPIA Support ARM Initiative on Hospital Exemptions and Call for Increased Transparency on All Advanced Cell, Gene and Tissue Therapies
16 February 2017

Brussels, 16 February 2017 - The European Biopharmaceutical Enterprises (EBE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) today express their support for key aspects of [...] Read more

From our blog

From our blog

CETA: a Cutting-Edge Agreement Worth Waiting for
16 February 2017 by Maria Trallero

There is a saying that all good things are worth waiting for, and CETA is one of them. The EU-Canada Comprehensive Economic and Trade Agreement, known as CETA, was negotiated for 7 full years and debated extensively in Europe and in Canada over that entire period.

Read more

Events calendar

Events Calendar

DIA BioVenture Day
On 28/03/2017 (Glasgow, UK)

DIA is excited to convene its 1st BioVenture Day, in a unique format with the participation of a very broad set of senior healthcare stakeholders. You will be able to explore whether the current BioVenture paradigm is delivering returns for patients, investors, and the healthcare system.

Read more

Events Calendar

DIA EuroMeeting 2017
From 29/03/2017 to 31/03/2017 (Glasgow, UK)

The DIA EuroMeeting 2017 is unique in presenting the entire healthcare microcosm, ranging from policy and regulations, to R&D marketing and access.

In an intense and stimulating three days, you will enjoy learning and debating. You will meet not only people you know, but also those that you want to know and those that you should know.

The DIA EuroMeeting allows you to debate the issues across the entire drug development value chain during the conference, and find solutions within the exhibition with 2,500+ other cross-functional thought leaders.

You will hear the latest solutions and challenges in healthcare. You will have plenty of opportunities to network and build relationships with trend-setters in e.g. the areas of regulatory science, clinical research and operations, value demonstration leads and patient advocates. The resulting knowledge transfer and lasting partnerships will reduce the burden of regulatory barriers, benefiting your business now and further down the line.

Read more

Events Calendar

Using Process Knowledge and Risk Management Tools to Build an Effective Control Strategy for Drug Substance Manufacture
On 15/03/2017 (Dublin, Ireland)

Dublin City University (DCU), in partnership with DCU Alpha (DCU's innovation campus) are proud to present an exciting initiative that promises to bring together high calibre speakers from the world of pharmaceutical and health regulation, to discuss topics centred on regulatory affairs and “the science of regulation”.

This one day symposium will focus on the manufacture and control of active pharmaceutical ingredients (API), and how to translate effectively knowledge of the chemistry, manufacturing and controls into a regulatory dossier.

Read more

Events Calendar

Biovision World Life Science Forum
From 04/04/2017 to 06/04/2017 (Lyon, France)

Biovision World Life Science Forum is fostering a unique approach to meet, connect and collaborate between international decision-makers from the academic, civil society, policy-making and private sectors whether industrials or investors. Biovision being the place to network and make the connections you need to secure partnerships, investments and contacts.

Presenting an impressive line-up of participants addressing evidence and research as well as development and promotion, the 2017 edition of the Biovision life sciences forum affirms its status as a standout gathering of knowledge among other such international meetings. This year, the forum will welcome major players from the health sector representing each step of the value chain (research, innovation, partnerships and finance) with the goal of arriving at concrete solutions to existing and future health issues.

Read more

Events Calendar

Certificate in Healthcare Compliance Ethics & Regulation
From 06/06/2017 to 09/06/2017 (Paris, France)

The Certificate in Healthcare Compliance Ethics & Regulation has been designed for Compliance Officers and Compliance Managers and Lawyers. It presents European and International Laws in the Health and Life Sciences Sector to provide a thorough understanding of the current stakes of the industry and increase participants’ knowledge and skills. Participants from all over the world will be immersed during a whole week into the legal framework of healthcare industries. They will discuss industry codes and work on cases and settlements with world-renown professionals. Organised with Seton Hall Law School, this program also takes place in the United Sates at Seton Hall Law School, Newark, NJ and in Singapore.

Audience: Compliance Officers and Compliance Managers from Pharmaceutical, Medical Device and Biotech Companies,  Lawyers representing the Health and Life Sciences Industry and Consultants to the Health and Life Sciences Industry

Purposes: Provide participants with in​-​depth knowledge of European and International Laws and Regulation,  Deepen the Understanding of how Ethics Codes are implemented and applied within the industry, Study Compliance Program and Cases to increase Awareness of Best Practices, and Apply this Legal Framework through Case Studies

Read more

Documents

From our blog

Optimising Post-Approval Change Management for Timely Access to Medicinal Worldwide
16 February 2017 (Position Papers)

Post-approval changes (PACs) to the registered information of authorised medicinal products, hereafter referred to as ‘variations’, are introduced routinely worldwide to: enhance the robustness and [...] Read more

What we are reading

What we are reading

Shout about the European Union’s success
16 February 2017 (Nature)

As people in other nations watch the UK prepare to sever ties, Herman Goossens urges more scientists to stress what the EU does for them.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail